Literature DB >> 7333700

Incidence of ovarian cancer in relation to the use of oral contraceptives.

N S Weiss, J L Lyon, J M Liff, W M Vollmer, J R Daling.   

Abstract

Female residents of six counties in Washington and Utah in whom a diagnosis of ovarian cancer was made during 1975-79 were interviewed concerning prior use of oral contraceptives. Interviews with a random sample of women drawn from these same counties were obtained for comparison. A smaller proportion of women with epithelial ovarian tumors had taken oral contraceptives than had controls: the estimated risk of ovarian cancer in uses relative to that in non-users was 0.57 (p = 0.04). The magnitude of the decreased risk depended on the duration over which oral contraceptives had been taken, as the negative association was present only after 4 or more years of use. In many ways, the use of oral contraceptives mimics the physiologic effects of pregnancy. The results of the present investigation, when interpreted together with those from other epidemiologic studies and from experiments in animals, suggest that, like pregnancy, the use of oral contraceptives has a protective effect against the development of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333700     DOI: 10.1002/ijc.2910280602

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Exogenous hormones in the aetiology of cancer in women.

Authors:  M P Vessey
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

Review 2.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States).

Authors:  A I Adler; N S Weiss; M L Kamb; J L Lyon
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

Review 4.  The relationship between oral contraceptive use, cancer and vascular disease.

Authors:  C La Vecchia; S Franceschi; P Bruzzi; F Parazzini; P Boyle
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 5.  Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer.

Authors:  Elizabeth Swisher
Journal:  Curr Treat Options Oncol       Date:  2003-04

6.  Oral contraceptive use and the risk of epithelial ovarian cancer.

Authors:  C La Vecchia; S Franceschi; A Decarli
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

7.  Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study.

Authors:  C La Vecchia; A Decarli; M Fasoli; S Franceschi; A Gentile; E Negri; F Parazzini; G Tognoni
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

8.  Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study.

Authors:  M Kumle; E Weiderpass; T Braaten; H-O Adami; E Lund
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.